Libo Zou

2.3k total citations
84 papers, 1.9k citations indexed

About

Libo Zou is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Libo Zou has authored 84 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 36 papers in Physiology and 23 papers in Cellular and Molecular Neuroscience. Recurrent topics in Libo Zou's work include Alzheimer's disease research and treatments (26 papers), Natural product bioactivities and synthesis (11 papers) and Mitochondrial Function and Pathology (10 papers). Libo Zou is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Natural product bioactivities and synthesis (11 papers) and Mitochondrial Function and Pathology (10 papers). Libo Zou collaborates with scholars based in China, Japan and Canada. Libo Zou's co-authors include Tianyan Chi, Xuefei Ji, Ge Jin, Qian Xu, Kiyofumi Yamada, Lihua Wang, Peng Liu, Toshitaka Nabeshima, Tsutomu Kameyama and Peng Liu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Libo Zou

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Zou China 28 920 534 368 325 319 84 1.9k
Erika Gyengési Australia 27 651 0.7× 625 1.2× 311 0.8× 324 1.0× 404 1.3× 51 2.2k
Hao Hong China 28 1.0k 1.1× 770 1.4× 297 0.8× 317 1.0× 614 1.9× 58 2.6k
Yossi Gilgun‐Sherki Israel 20 949 1.0× 437 0.8× 405 1.1× 301 0.9× 434 1.4× 39 2.8k
Mohammed Akbar United States 30 1.3k 1.4× 630 1.2× 386 1.0× 231 0.7× 237 0.7× 50 3.2k
Izaskun Buendía Spain 26 1.3k 1.4× 525 1.0× 294 0.8× 345 1.1× 727 2.3× 41 2.7k
Yasuhiko Izumi Japan 31 1.1k 1.1× 414 0.8× 463 1.3× 295 0.9× 378 1.2× 82 2.3k
Yuangui Zhu China 27 926 1.0× 866 1.6× 342 0.9× 242 0.7× 584 1.8× 46 2.2k
Hisashi Shirakawa Japan 29 798 0.9× 659 1.2× 817 2.2× 222 0.7× 425 1.3× 110 2.6k
Pradip K. Kamat United States 31 991 1.1× 818 1.5× 378 1.0× 444 1.4× 524 1.6× 56 2.7k

Countries citing papers authored by Libo Zou

Since Specialization
Citations

This map shows the geographic impact of Libo Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Zou more than expected).

Fields of papers citing papers by Libo Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Zou. The network helps show where Libo Zou may publish in the future.

Co-authorship network of co-authors of Libo Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Zou. A scholar is included among the top collaborators of Libo Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Zou. Libo Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Na, Danyang Liu, Peng Liu, et al.. (2025). OAB-14 alleviates mitochondrial impairment through the SIRT3-dependent mechanism in APP/PS1 transgenic mice and N2a/APP cells. Free Radical Biology and Medicine. 228. 360–378. 2 indexed citations
2.
Zhang, Xian, Luxi Yang, Na Zheng, et al.. (2023). Mechanism of anti-AD action of OAB-14 by enhancing the function of glymphatic system. Neurochemistry International. 171. 105633–105633. 5 indexed citations
3.
Zhang, Feng, Peng Liu, Tianyan Chi, et al.. (2023). The bexarotene derivative OAB-14 ameliorates cognitive decline in APP/PS1 transgenic mice by suppressing microglia-mediated neuroinflammation through the PPAR-γ pathway. International Immunopharmacology. 124(Pt A). 110911–110911. 6 indexed citations
5.
Mouri, Akihiro, Kazuo Kunisawa, Yuko Mori, et al.. (2019). Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression. Behavioural Brain Research. 372. 112053–112053. 71 indexed citations
6.
Jin, Ge, Lin Zhu, Peng Liu, et al.. (2019). Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice. The Journal of Physiological Sciences. 69(3). 477–488. 20 indexed citations
7.
Liu, Peng, Rui Zhang, Danyang Liu, et al.. (2017). Time-course investigation of blood–brain barrier permeability and tight junction protein changes in a rat model of permanent focal ischemia. The Journal of Physiological Sciences. 68(2). 121–127. 38 indexed citations
8.
Qi, Yue, Xuefei Ji, Tianyan Chi, et al.. (2017). Xanthoceraside attenuates amyloid β peptide 1-42 -induced memory impairments by reducing neuroinflammatory responses in mice. European Journal of Pharmacology. 820. 18–30. 26 indexed citations
9.
Zou, Libo, Peng Liu, Qian Xu, et al.. (2014). Xanthoceraside Induces Apoptosis in Melanoma Cells Through the Activation of Caspases and the Suppression of the IGF-1R/Raf/MEK/ERK Signaling Pathway. Journal of Medicinal Food. 17(10). 1070–1078. 18 indexed citations
10.
Jin, Ge, Lihua Wang, Xuefei Ji, et al.. (2014). Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Neuroscience Letters. 573. 58–63. 39 indexed citations
11.
Zou, Libo. (2010). Protective effects of xanthoceraside on learning and memory impairment induced by intracerebroventricular injections of Aβ_(1-42) in mice. Shenyang Yaoke Daxue xuebao. 6 indexed citations
12.
Zou, Libo. (2009). Effect of Six Extractions from Wuhu Decoction on Isolated Tracheal Smooth Muscle in Guinea Pig. Zhongguo shiyan fangjixue zazhi. 4 indexed citations
13.
Lu, Chunfeng, Yimei Wang, Shuangqing Peng, et al.. (2009). Combined Effects of Repeated Administration of 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Polychlorinated Biphenyls on Kidneys of Male Rats. Archives of Environmental Contamination and Toxicology. 57(4). 767–776. 19 indexed citations
14.
Chi, Tianyan, Lihua Wang, Xuefei Ji, et al.. (2009). Protective effects of xanthoceraside on learning and memory impairment induced by Aβ25–35in mice. Journal of Asian Natural Products Research. 11(12). 1019–1027. 28 indexed citations
15.
Zou, Libo. (2008). Progress in the development of early-onset antidepressants. Zhongguo yaolixue tongbao. 1 indexed citations
16.
Zou, Libo. (2007). Improvement of ethanol extract from husk of Xanthoceras sorbifolia on rats with learning and memory dysfunction. Zhongcaoyao. 11 indexed citations
17.
Zou, Libo, et al.. (2007). 6,7-di-O-glucopyranosyl-esculetin protects SH-SY5Y cells from dopamine-induced cytotoxicity. European Journal of Pharmacology. 580(3). 329–338. 17 indexed citations
18.
Zou, Libo. (2006). Effect of Qingdaisan on ulcerative colitis in rats. 1 indexed citations
19.
Yamada, Kiyofumi, Tomoko Tanaka, Libo Zou, et al.. (1999). Long‐term deprivation of oestrogens by ovariectomy potentiates β‐amyloid‐induced working memory deficits in rats. British Journal of Pharmacology. 128(2). 419–427. 49 indexed citations
20.
Liu, Mingsheng, et al.. (1996). Studies on the Anti-oxidation active constituents of Rhapontium uniflorum (I). Zhongguo yaowu huaxue zazhi. 6(2). 121–124. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026